Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/16/2005WO2005007144A3 Method of diagnosis and treatment for asthma based on haplotype association
06/16/2005WO2005007117A3 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
06/16/2005WO2005007098A3 Nucleic acid therapy to enhance cartilage repair
06/16/2005WO2005004854A3 Use of betaine for treating arteritis
06/16/2005WO2005002576A3 Imidazole derivatives and their use as protein kinases inhibitors
06/16/2005WO2005002554A3 A method of promoting sleep using topical administration of vasoactive agents
06/16/2005WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors
06/16/2005WO2004112794A3 New pharmaceutical uses of staurosporine derivatives
06/16/2005WO2004105727A3 Stabilized pharmaceutical product
06/16/2005WO2004096286A3 Antiviral phosphonate analogs
06/16/2005WO2004096233A3 Nucleoside phosphonate conjugates
06/16/2005WO2004093881A3 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
06/16/2005WO2004087877A3 Selected rna motifs to include cell death and/or apoptosis
06/16/2005WO2004084817A3 Siderophore conjugates of photoactive dyes for photodynamic therapy
06/16/2005WO2004084816A3 IMPROVED CD4-IgG2 FORMULATIONS
06/16/2005WO2004071404A3 Use of il-6 antagonists in combination with steroids to enhance apoptosis
06/16/2005WO2004071400A3 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
06/16/2005WO2004060314A3 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
06/16/2005WO2004058753A8 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
06/16/2005WO2004056750A8 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors
06/16/2005WO2004035006A3 Methods and compositions for immunization against hiv
06/16/2005WO2004033436A8 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
06/16/2005WO2004017904A3 Corticosteroid conjugates and uses thereof
06/16/2005WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof
06/16/2005WO1991001624A8 Use of calcium antagonists for treating scars
06/16/2005WO1990011078A8 Regional chemotherapy with 4-hydroperoxycyclophosphamide
06/16/2005WO1990006121A8 Method for improving reproductive functions in mammals
06/16/2005WO1990000853A8 Method of treating neurological disorders
06/16/2005US20050132430 Igamete recruitment and developmental competence in mammals by inhibiting the de-nova sterol biosynthesis and/or promoting sterol efflux
06/16/2005US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/16/2005US20050131363 Fiber substrate with odor absorbent
06/16/2005US20050131337 Analgesic drug delivery; skin discolroation inhibition
06/16/2005US20050131242 2-substituted vitamin d derivatives
06/16/2005US20050131238 Using substituted maleimide compound
06/16/2005US20050131237 Indole derivatives
06/16/2005US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases
06/16/2005US20050131227 Synthesis of temozolomide and analogs
06/16/2005US20050131224 Method for preparing radiolabeled thymidine
06/16/2005US20050131161 Process for removing bile salts from a patient and alkylated compositions therefor
06/16/2005US20050131138 Drug; therapy for kidney disease; removal of phosphates; gastrointestinal disorders
06/16/2005US20050131079 Powder mixture with water; therapy for infections, inflammation of ears, throat
06/16/2005US20050131078 Polycosanols from ericerus pela wax
06/16/2005US20050131077 On surface of skin or mucous membranes; topical applying
06/16/2005US20050131076 Delta15-D-Homosteroids with androgenic action
06/16/2005US20050131074 Methods for treating metabolic syndrome
06/16/2005US20050131072 Bronchodilator; side efect reduction
06/16/2005US20050131071 Orodispersible pharmaceutical composition of agomelatine
06/16/2005US20050131070 Process for preparing 4-pentafluorosulfanylbenzoylguanidines
06/16/2005US20050131069 N-Hydroxyalkyl-tetramethylcyclopropane carboxamide for treatment of headache, neurodegenerative diseases
06/16/2005US20050131068 Therapy for lipid disorders; dyslipidemia; insulin resistance; antidiabetic agents; 4-(2-(((2,6-dichlorophenyl)methyl)thio)ethyl) amino)-2-oxoethoxxy methoxybenzenepropanoic acid
06/16/2005US20050131067 Novel polymorphs of tolterodine tartrate
06/16/2005US20050131066 Crystalline ammonium salts of rosuvastatin
06/16/2005US20050131065 Active substance combination of creatine and/or creatinine and a retinoid
06/16/2005US20050131064 Administering powder or aerosol to nasal mucous membrane
06/16/2005US20050131063 Methods and composition based on discovery of metabolism of nitroglycerin
06/16/2005US20050131062 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
06/16/2005US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes
06/16/2005US20050131059 Anti-cancer combinations
06/16/2005US20050131058 Novel compounds and antimalarials
06/16/2005US20050131057 Taxane chemosensitivity prediction test
06/16/2005US20050131052 Useful in treatment of type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity
06/16/2005US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon
06/16/2005US20050131049 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
06/16/2005US20050131048 Enhancement of bone growth and inhibition of bone resorption
06/16/2005US20050131047 cardiovascular disorders
06/16/2005US20050131046 Administering to a human a therapeutically effective amount of descarboethoxyloratadine
06/16/2005US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131040 Reacting losartan and poltassium compound in presence of water and aprotic solvent; salt formation
06/16/2005US20050131038 Process for the preparation of valsartan and intermediates thereof
06/16/2005US20050131036 E.g., 5-(5-ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-methoxyphenyl)isoxazole, 5-(2,4-dimethoxy-5-ethylphenyl)-4-(4-bromophenyl)isoxazole or 5-(2,4-dihydroxy-5-etylphenyl)-4-(4-hydroxyphenyl)isoxazole, used for treating cancer cell migration, rheumatoid arthritis, psoriasis or other angiogenesis diseases
06/16/2005US20050131035 Medicaments
06/16/2005US20050131034 Moderator neurotransmitter release; central nervous ystem disorders ; using a N-methyl-5-(pyrimidyl or pyridyl)-4-penten-2-amine
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131031 Blending measure concentration of nicotine into solution ; accuray dosage
06/16/2005US20050131030 Regioselective halogenation of nicotine and substituted nicotines
06/16/2005US20050131029 Immunophilin ligand treatment of antiretroviral toxic neuropathy
06/16/2005US20050131028 Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
06/16/2005US20050131027 Fine particle size pioglitazone
06/16/2005US20050131026 Bronchitis; chronic obstructive pulmonary disease; antihistamines; pneumonia
06/16/2005US20050131025 In situ applying to eye
06/16/2005US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents
06/16/2005US20050131023 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
06/16/2005US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer
06/16/2005US20050131021 Phenoxy piperidines for treating diseases such as schizophrenia and depression
06/16/2005US20050131020 N-type calcium channel antagonists for the treatment of pain
06/16/2005US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050131016 Chemical compounds
06/16/2005US20050131015 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
06/16/2005US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents
06/16/2005US20050131013 5,7-Dibromo-8-(2-hydroxyethyl) quinoline and 5,7-dibromo-8-(2-methoxycarbonyloxyethyl) quinoline, for treating plant diseases
06/16/2005US20050131012 Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
06/16/2005US20050131011 Antiinflammatory agents; viricides against human t-cell/lymphoma virus or retroviruses
06/16/2005US20050131009 Urea substituted imidazoquinolines
06/16/2005US20050131007 Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
06/16/2005US20050131006 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
06/16/2005US20050131005 4-azasteroid derivatives as androgen receptor modulators
06/16/2005US20050131004 8-[2-(6,6-Dimethyl-bicyclo[3.1.1]hept-2-yl)-ethyl]-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one and derivatives; treating metabolic, gastrointestinal, urogenital, renal, cardiovascular, opthalmological, respiratory, and immunological disorders and viral infections; especially diarrhea and visceral pain
06/16/2005US20050131003 Heterocyclic compounds
1 ... 4649 4650 4651 4652 4653 4654 4655 4656 4657 4658 4659 4660 4661 4662 4663 4664 4665 4666 4667 4668 4669 ... 7860